Cardiac antibody-mediated rejection. - Wikidata - wikimedia - TriplyDB

Cardiac antibody-mediated rejection.

Cardiac antibody-mediated rejection.

http://www.wikidata.org/entity/Q38002449

about

Bortezomib use in a pediatric cardiac transplant center.Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes.Tandem hemodialysis and plasma exchange.Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation.

P2860

Q33415926-AD10FA44-0AEF-4661-9321-5EBCFCEBFC0D Q37609092-164ED4B3-F710-4C55-B9F8-0B06D844E0E7 Q38136092-FAFB879A-7646-4EE8-947B-3025B9A52B40 Q48149010-C63AAAEE-988E-43F7-B787-C0129D50DCD6

P2860

Cardiac antibody-mediated rejection.

http://www.wikidata.org/entity/Q38002449

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cardiac antibody-mediated rejection.

@en

type

label

Cardiac antibody-mediated rejection.

@en

prefLabel

Cardiac antibody-mediated rejection.

@en

P1433

Q38002449-9EECACF6-5C45-42FE-B0D8-48855D4CE8B1

P1476

Q38002449-189667DB-9665-4093-B9F5-2DD72B105063

P2093

Q38002449-29A405A8-4A58-425B-A3D5-4C22E19D29B3

P2860

Q38002449-02F0AB0A-B819-450E-BD31-1B54B884EE5B

Q38002449-06A6BA51-D3B2-4F6A-A756-5E443803777A

Q38002449-0E5939F9-0471-478C-9FCB-9FB7F658756A

Q38002449-101AE2B2-1D84-4B0F-8A0F-7FE4271598E5

Q38002449-1170B4F7-F9CE-4C44-A221-6CC6CD0116B7

Q38002449-2096C806-CF25-438F-9564-4AB06AD04F1F

Q38002449-234E571B-7A88-4E15-8329-3AE99780828C

Q38002449-296F5DC5-0E8E-4863-8249-D304B94A2FA8

Q38002449-3885C24A-B93E-4C47-B3A2-B6F2F325DF90

Q38002449-39E25011-D3F0-42F0-81B4-9752C6B9BD7A

P304

Q38002449-5C34875C-5E07-4DF1-88D5-437896F6D626

P31

Q38002449-C4FE5696-BFBF-40E7-9F64-87B7B882505D

P356

Q38002449-2B992057-D145-4575-9683-AF1DF02004ED

P433

Q38002449-A3952DB7-0043-488D-89EB-41902C691FB5

P478

Q38002449-8C927FF8-B7E6-4141-933F-15BC9539A7BE

P577

Q38002449-8016CA45-4DF0-4F3F-A7A1-93C70F377D2B

P698

Q38002449-D60D9B1E-9DAF-4A17-907B-6C5D9D79649E

P356

J.1399-3046.2012.01690.X

P1433

Pediatric Transplantation

P1476

Cardiac antibody-mediated rejection.

@en

P2093

Clifford Chin

http://www.w3.org/2001/XMLSchema#string

P2860

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.

Proteasome inhibition reduces donor-specific antibody levels.

Abrogation of anti-HLA antibodies via proteasome inhibition.

Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Presensitization: the problem and its management.

Immunology and failure of valved allografts in children.

Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.

Allosensitization in heart transplantation: implications and management strategies.

P304

404-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-3046.2012.01690.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22500558

http://www.w3.org/2001/XMLSchema#string